Literature DB >> 23485406

Genomic causes of multiple cerebral cavernous malformations in a Japanese population.

Satoshi Tsutsumi1, Ikuko Ogino, Masakazu Miyajima, Tomomi Ikeda, Noriko Shindo, Yukimasa Yasumoto, Masanori Ito, Hajime Arai.   

Abstract

Cerebral cavernous malformation (CCM) is a hamartomatous vascular disease affecting the central nervous system. A fraction of CCM are thought to arise in association with genomic mutations in the cerebral cavernous malformation 1 (CCM1) (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10) genes. In the present study, 18 Japanese patients with multiple CCM (10 with familial type and eight with sporadic type), underwent genomic analysis for CCM1, CCM2 and CCM3 mutations with blood samples and surgical specimens. MRI showed CCM in the cerebral hemisphere in 17 patients, the cerebellum in 10, the brainstem in 10 and the spinal cord in eight. CCM2 mutations were the most prominent, followed by CCM1 and CCM3. CCM1, CCM2 and CCM3 mutations were not identified in seven patients. Among the 10 patients with familial CCM, CCM1, CCM2 and CCM3 mutations were found in two, three and one patient, respectively, whereas four patients lacked these mutations. Among the eight patients with sporadic CCM, these mutations were found in one, three, and one patients, respectively, whereas three patients lacked these mutations. Most of the patients had a stable course during the follow-up period. Genomic mutations other than CCM1, CCM2 and CCM3 may be frequent in patients with multiple CCM in the Japanese population.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485406     DOI: 10.1016/j.jocn.2012.05.041

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  8 in total

Review 1.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

2.  Familial cerebral cavernous angiomas: clinical and genetic features in a Chinese family with a frame-shift mutation in the CCM1 gene (krit1).

Authors:  Hui Zhu; Yingjie Guo; Xuemin Feng; Rensheng Zhang; Chunkui Zhou; Guibo Li; Jingyao Liu
Journal:  J Mol Neurosci       Date:  2014-09-04       Impact factor: 3.444

3.  A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.

Authors:  Hui Wang; Yunzhu Pan; Zaiqiang Zhang; Xingang Li; Zhe Xu; Yue Suo; Wei Li; Yongjun Wang
Journal:  J Mol Neurosci       Date:  2017-02-03       Impact factor: 3.444

4.  Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.

Authors:  Rosalia D'Angelo; Concetta Alafaci; Concetta Scimone; Alessia Ruggeri; Francesco Maria Salpietro; Placido Bramanti; Francesco Tomasello; Antonina Sidoti
Journal:  Biomed Res Int       Date:  2013-08-22       Impact factor: 3.411

Review 5.  Introduction to cerebral cavernous malformation: a brief review.

Authors:  Jaehong Kim
Journal:  BMB Rep       Date:  2016-05       Impact factor: 4.778

6.  In-silico analysis of nonsynonymous genomic variants within CCM2 gene reaffirm the existence of dual cores within typical PTB domain.

Authors:  Akhil Padarti; Ofek Belkin; Johnathan Abou-Fadel; Jun Zhang
Journal:  Biochem Biophys Rep       Date:  2022-01-27

7.  A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the CCM1 Gene: A Case Report and Review of the Literature.

Authors:  Wenyu Liu; Ming Liu; Di Lu; Jiwei Wang; Zexin Cao; Xuchen Liu; Zichao Feng; Bin Huang; Xinyu Wang
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

8.  Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.

Authors:  Kazuhiro Ishii; Naoki Tozaka; Satoshi Tsutsumi; Ai Muroi; Akira Tamaoka
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.